Download Clinical Trials at Advocate Health and AMITA Health

Hospital Location
Advocate Condell Hospital
Clinical Trial Description
NSABP-51/RTOG1304-Randomized Phase III
Clinical Trial Evaluating Post-Mastectomy
Chestwall and Regional Nodal XRT and PostLumpectomy Regional Nodal XRT in Patients with
Positive Axillary Nodes Before Neoadjuvant
Chemotherapy Who Convert to Pathologically
Negative Axillary Nodes After Neoadjuvant
Chemotherapy
Alliance 011202 trial will enroll patients who are
not eligible for NSABP B-51/RTOG 1304 due to
the presence of positive sentinel nodes after
neoadjuvant chemotherapy. –
Identification of Reasons Why Oncology patients
Who Report Elevated Levels of Stress Decline
Offers of Help and Resources
Advocate Good Shepherd Hospital
Identification of Reasons Why Oncology patients
Who Report Elevated Levels of Stress Decline
Offers of Help and Resources
IRB # 6118 Quality of Life between group
difference for internal vs. external locus of
control in a cancer patient population.
IRB#5307 Prospective Evaluation of CyberKnife as
Monotherapy or Boost Stereotactic Body
Radiotherapy (SBRT) for Intermediate or High
Risk Localized Prostate Cancer
Advocate Illinois Masonic Hospital
CALGB 30610 (RTOG 0538) Phase III Comparison
of Thoracic Radiotherapy Regimens in Patients
With Limited Small Cell Lung Cancer Also
Receiving Cisplatin and Etoposide
RTOG 0534 Phase III Trial of Short Term Androgen
Deprivation with Pelvic Lymph Node or Prostate
Bed only Radiotherapy (SSPORT) in prostate
Cancer Patients with a Rising PSA after Radical
Prostatectomy
RTOG 1005: A Phase III Trial of Accelerated
Whole Breast Irradiation with Hypofractionation
Plus Concurrent Boost versus Standard Whole
Breast Irradiation Plus Sequential Boost for Early
Stage Breast Cancer
Phase III Prospective Randomized Trial of DoseEscalated Radiotherapy With or Without ShortTerm Androgen Deprivation Therapy for Patients
With Intermediate-Risk Prostate Cancer
RTOG 1005: A Phase III Trial of Accelerated
Whole Breast Irradiation with Hypofractionation
Plus Concurrent Boost versus Standard Whole
Breast Irradiation Plus Sequential Boost for Early
Stage Breast Cancer
N0877: Phase I/Randomized Phase II Trial of
either Dasatinib or Placebo Combined with
Standard Chemo-Radiotherapy for Newly
Diagnosed Glioblastoma Multiforme (GBM)
Phase I/II Trial to Evaluate Accelerated Partial
Breast Irradiation as Sole Radiation Treatment
after Lumpectomy in Early Stage Breast Cancer
Patients
Radiation Therapy With Cisplatin or Cetuximab in
Treating Patients With Oropharyngeal Cancer
Identification of Reasons Why Oncology patients
Who Report Elevated Levels of Stress Decline
Offers of Help and Resources
Phase III Intergroup Study of Temozolomide
Alone Versus Radiotherapy With Concomitant
and Adjuvant Temozolomide Versus
Radiotherapy With Adjuvant PCV Chemotherapy
in Patients With 1p/19q Co-deleted Anaplastic
Glioma
Higher-Dose Radiation Therapy or Standard
Radiation Therapy in Treating Patients With EarlyStage Breast Cancer That Was Removed by
Surgery
NSABP PROTOCOL DMP-1: A Study to Evaluate
Different Decision-Making Approaches Used by
Women Known to be at Increased Risk for Breast
Cancer
Advocate Lutheran General Hospital
GOG-0258: A RANDOMIZED PHASE III TRIAL OF
CISPLATIN AND TUMOR VOLUME DIRECTED
IRRADIATION FOLLOWED BY CARBOPLATIN AND
PACLITAXEL VS. CARBOPLATIN AND PACLITAXEL
FOR OPTIMALLY DEBULKED, ADVANCED
ENDOMETRIAL CARCINOMA.
GOG-0249: A PHASE III TRIAL OF PELVIC
RADIATION THERAPY VERSUS VAGINAL CUFF
BRACHYTHERAPY FOLLOWED BY
PACLITAXEL/CARBOPLATIN CHEMOTHERAPY IN
PATIENTS WITH HIGH RISK, EARLY STAGE
ENDOMETRIAL CARCINOMA.
Phase I/II Trial to Evaluate Accelerated Partial
Breast Irradiation as Sole Radiation Treatment
after Lumpectomy in Early Stage Breast Cancer
Patients
Paclitaxel, Cisplatin, and Radiation Therapy With
or Without Cetuximab in Treating Patients With
Locally Advanced Esophageal Cancer
NSABP B-43: A Phase III Clinical Trial Comparing
Trastuzumab Given Concurrently with Radiation
Therapy and Radiation Therapy Alone for Women
with HER2-Positive Ductal Carcinoma In Situ
Resected by Lumpectomy.
A Randomized Phase III Study of Conventional
Whole Breast Irradiation (WBI) Versus Partial
Breast Irradiation (PBI) for Women with Stage 0,
I, or II Breast Cancer
Identification of Reasons Why Oncology patients
Who Report Elevated Levels of Stress Decline
Offers of Help and Resources
Illinois Cyberknife at Advocate Lutheran General
Hospital
Prospective Evaluation of CyberKnife® as
Monotherapy or Boost Stereotactic Body
Radiotherapy (SBRT) for Intermediate or High
Risk Localized Prostate Cancer: An Observational
Study
Prospective Evaluation of Low-Dose Irinotecan
and Cyberknife Stereotactic Body Radiotherapy in
the Treatment of Patients with Colorectal Cancer
and Limited Liver Metastasis
AMITA Health – Alexian Brothers
B51 A Randomized Phase III Clinical Trial
Evaluating Post-Mastectomy Chest wall and
Regional Nodal XRT and Post-Lumpectomy
Regional Nodal XRT in Patients with Positive
Axillary Nodes Before Neoadjuvant
Chemotherapy Who Convert to Pathologically
Negative Axillary Nodes After Neoadjuvant
Chemotherapy